openPR Logo
Press release

Lyme Disease Treatment Market Growth Trends, Current Demand, and Development Report by 2021-2031

07-04-2022 06:23 AM CET | Health & Medicine

Press release from: Transparency Market Research

Lyme Disease Treatment Market: Introduction

According to the report, the global Lyme disease treatment market was valued at US$ 1.58 Bn in 2020 and is projected to expand at a CAGR of ~6% from 2021 to 2031. Increase in pet ownership, surge in awareness & adoption of veterinary care, and rise in healthcare expenditure on animals are anticipated to drive the global Lyme disease treatment market from 2021 to 2031.North America is expected to account for a significant share of the global Lyme disease treatment market during the forecast period. The growth of the Lyme disease treatment market in the region can be attributed to rise in access to healthcare and increase in incidence of Lyme disease.

Report Overview: https://www.transparencymarketresearch.com/lyme-disease-therapeutics-market.html

The market in Asia Pacific is likely to expand at a high CAGR from 2021 to 2031. The emergence of vector borne diseases in the region is projected to boost the growth of the market in the region. An article published in the National Library of Medicine stated that the prevalence rate of Lyme disease in northeast China was 1% to 4%. Moreover, rise in awareness about emerging tick-borne pathogens is anticipated to fuel the growth of the global market over the next few years.

Rise in Prevalence of Lyme Disease to Propel Market

Lyme disease is the most common vector-borne disease. Climate is one of the many important factors that influences the transmission, distribution, and incidence of Lyme disease. Additionally, climate change leads to rise in the survival and activity period of ticks, and increases in the potential risk of Lyme disease. Other factors that affect the number of Lyme disease cases are changes in the population of host species (particularly deer), which affect tick population size.The incidence of Lyme disease in the U.S. has nearly doubled since 1991, from 3.74 reported cases per 100,000 people to 7.95 reported cases per 100,000 in 2014. According to the Centers for Disease Control and Prevention, 20,000 to 30,000 confirmed cases of Lyme disease have been reported in the U.S. per year. Lyme disease is most common in New Hampshire, Maine, and Vermont, which have experienced the largest increase in reported case rates since 1991.

According to the World Health Organization, the number of cases in Europe has increased steadily; more than 360,000 cases having been reported over the past two decades. According to the Westgate Pet Clinic, 5% to 15% canines are infected by Lyme disease. Hence, rise in prevalence of Lyme disease in both animals and humans is anticipated to boost the growth of the global market.

Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=76335

Medication to Dominate Market
In terms of test type, the global Lyme disease treatment market has been bifurcated into medication and tick removal. The medication segment is expected to dominate the global Lyme disease treatment market from 2021 to 2031.

A range of FDA-approved medications such as antibiotics and NSAIDs are available to treat the early stage Lyme disease. This drives the segment.
The antibiotics sub-segment is projected to lead the medication segment during the forecast period. Patients with Lyme disease usually recover rapidly and completely with appropriate antibiotics in the early stages. This contributes to the growth of the sub-segment. Cephalosporin, tetracycline, and macrolides antibiotics are commonly prescribed for the treatment of Lyme disease.

Oral Route of Administration to be Preferred
Based on route of administration, the global Lyme disease treatment market has been divided into oral, injectable, and topical. The oral segment is likely to grow at a higher CAGR from 2021 to 2031.
The availability of products administered through oral route is projected to drive the segment.
Physicians recommend doxycycline as the preferred agent for oral treatment of Lyme disease, due to its activity against other tick-borne illnesses.

Request for covid19 Impact Analysis: https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=76335

Retail Pharmacies to be Key Distribution Channel
In terms of distribution channel, the global Lyme disease treatment market has been classified into hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment is projected to lead the global Lyme disease treatment market during the forecast period. The preference for distribution through retail pharmacy is anticipated to propel the segment.
Competition Landscape in Lyme Disease Treatment Market

The report provides profiles of leading players operating in the global Lyme disease treatment market. These include GlaxoSmithKline plc, Pfizer, Inc., Novartis AG, F. Hoffmann-La Roche Ltd., Almirall, LLC, Mayne Pharma, Boehringer Ingelheim International GmbH, Galderma Laboratories, L.P., Lupin Pharmaceuticals, Inc., Chartwell Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Orion Corporation, and Amneal Pharmaceuticals LLC.

More Trending Reports by Transparency Market Research:

Chronic Obstructive Pulmonary Disease (COPD)
Treatment Market:
https://www.transparencymarketresearch.com/chronic-obstructive-pulmonary-disease-copd-treatment-market.html

Chronic Pelvic Pain Treatment Market: https://www.transparencymarketresearch.com/chronic-pelvic-pain-treatment-market.html

Nonalcoholic Steatohepatitis Therapeutics Market: https://www.transparencymarketresearch.com/nonalcoholic-steatohepatitis-market.html

Psoriasis Treatment Market: https://www.transparencymarketresearch.com/psoriasis-treatment-market.html

Life Science Reagents Market: https://www.transparencymarketresearch.com/life-sciences-reagents-analytical-reagents.html

Liquid Filled Hard Capsules Market: https://www.transparencymarketresearch.com/liquidfilled-hard-capsules-market.html

Antihypertensive Drugs Market: https://www.transparencymarketresearch.com/antihypertensive-drugs-market.html

Controlled Substance Market: https://www.transparencymarketresearch.com/us-controlled-substance-market.html

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lyme Disease Treatment Market Growth Trends, Current Demand, and Development Report by 2021-2031 here

News-ID: 2669922 • Views: 231

More Releases from Transparency Market Research

Paperboard Packaging Market Compelling Long-Term Growth Story for the forecast y …
The growth of paperboard packaging market is witnessing steady growth of sales from growing utilization of this versatile material in multiple end-use industries. Revenues in paper and paperboard food packaging have grown remarkably on the back of the need for sturdy, lightweight, and printable-friendly packaging materials. The global paperboard packaging market is projected to reach valuation of US$ 299.4 Mn by 2031. Access Complete Report of Paperboard Packaging Market @ https://www.transparencymarketresearch.com/paperboard-market.html Enormous
On-the-Go Breakfast Packaging Market Size, Business Revenue Forecast, Leading Co …
Transparency Market Research (TMR) provides key valuable insights into the on-the-go breakfast packaging market in its published report, which incorporates global industry analysis, size, share, growth, opportunities, trends, and forecast for 2021-2029. In terms of revenue, the global market is anticipated to expand 1.6 times of current market value by the end of 2029, due to increasing demand for flexible packaging across several countries, about which TMR offers detailed insights
Interleaving Papers Market Industry Growth Situation and Prospects Research 2028
Smooth or fine surface finish not only adds to the aesthetics of a product but also enables the product manufacturer to claim for a higher price and still achieve consumer satisfaction. To make very fine surface finish, high investment on processing machinery is required. Further, this finish can be easily deteriorated by physical shocks experienced during transportation or handling of the product in bulk. Thus, interleaving papers play a crucial
Lamination Films Market Key Players and Production Information analysis with For …
Transparency Market Research (TMR) provides key valuable insights into the lamination films market in its published report, which incorporate global industry analysis, size, share, growth, opportunities, trends, and forecast for 2021-2029. In terms of revenue, the global market is anticipated to expand 1.6 times of current market value, by the end of 2029, considering to increasing demand for flexible packaging across several countries, about which TMR offers detailed insights and

All 5 Releases


More Releases for Lyme

Lyme Disease Diagnostic Testing Market
The report presents a detailed analysis of the Lyme disease diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Lyme disease definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs
Lyme Disease Diagnostics Market - Global Industry Insights, Trends, 2026
Lyme disease occurs due to bacterium Borrelia burgdorferi (Bb) and is transmitted to humans through the bite of infected blacklegged ticks. Its general symptoms include fatigue, headache, fever and a skin rash called erythema migrans. The infection can spread to heart, nervous system and joints if left untreated. Centers for Disease Control and Prevention (CDC) recommends a two-step process to diagnose Lyme infection. The first step uses a testing procedure
Releases New Report on the Lyme Disease Diagnostic Market
Lyme disease is an infectious disease caused by bacterial species borrelia. It is a tick borne disease caused by the transmission to humans by the bite of infected ticks. Patients infected with lyme disease suffer from symptoms such as fever, depression, fatigue and skin rashes. If the disease is diagnosed at an early stage then it can be treated with antibiotics. However, if the disease is left untreated then it
Global Lyme Disease and Companies Pipeline Review H1 2018
Summary Lyme disease is a bacterial infection transmitted by a tick. Lyme disease is caused by the bacterium Borrelia burgdorferi. Symptoms include rash, fever, chills, fatigue, body aches and headache. Risk factors include age, gender and geographic locations. Treatment includes antibiotics. Report Highlights Pharmaceutical and Healthcare latest pipeline guide Lyme Disease - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Lyme Disease (Infectious Disease), complete with analysis by
Lyme Disease Diagnostic Market : Segmentation and Product Research 2019
Lyme disease is an infectious disease caused by bacterial species borrelia. It is a tick borne disease caused by the transmission to humans by the bite of infected ticks. Patients infected with lyme disease suffer from symptoms such as fever, depression, fatigue and skin rashes. If the disease is diagnosed at an early stage then it can be treated with antibiotics. However, if the disease is left untreated then it
Lyme Disease Vaccine Market 2017 - Merck, Merial, Zoetis
Market Reports.biz, recently published a detailed market research study focused on the " Lyme Disease Vaccine Market" across the global, regional and country level. The report provides 360° analysis of " Lyme Disease Vaccine Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Lyme Disease Vaccine industry, and estimates the